Intravital Pty Ltd was started through the vision of a diverse group of leading clinicians and academics to create targeted therapies to prevent and treat nerve injury. Our approach has been to integrate the science at the forefront of our respective crafts while maintaining a focus on patient safety, feasibility and user experience. Our endeavour, born out of the science of cell preservation and neuroprotection, has proliferated a pipeline of therapies to address large unmet clinical needs and drive the next generation of clinical products.

Our development strategy focuses on impact. We want to be responsible for reducing disease burden and suffering in society. By integrating diverse skillsets and building teams with shared purpose, we can bring new therapies to market which fill important clinical gaps.

Our clinical product development pipeline currently has three streams: nerve protection (Senso), arthritis (Elevate Osteo) and nasal spray technologies (Naris Therapeutics).